Flagship explainer
How Pyxis Oncology, Inc. makes its money
Start with a dollar of revenue and follow what the filing says remains.
Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.
| Filed line | Value | % of revenue | Source |
|---|---|---|---|
| $13.9M | 100% |
| |
| Cost of revenue | $2.4M | 17% |
|
| $11.5M | 83% |
| |
| −$84.4M | −609% |
| |
| Income before tax | −$78.2M | −565% |
|
| Income tax | $1.4M | 10% |
|
| −$79.6M | −575% |
|
Source:
- SEC filing · FY 2025Filing detailsAccession 0001193125-26-118532